Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine

BACKGROUND: Patients with coronary microvascular dysfunction (CMD) often have diastolic dysfunction, representing an important therapeutic target. Ranolazine—a late sodium current inhibitor—improves diastolic function in animal models and subjects with obstructive coronary artery disease (CAD). HYPO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cardiol
Asıl Yazarlar: Nelson, Michael D., Sharif, Behzad, Shaw, Jaime L., Cook‐Wiens, Galen, Wei, Janet, Shufelt, Chrisandra, Mehta, Puja K., Thomson, Louise E. J., Berman, Daniel S., Thompson, Richard B., Handberg, Eileen M., Pepine, Carl J., Li, Debiao, Bairey Merz, C. Noel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley Periodicals, Inc. 2016
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436931/
https://ncbi.nlm.nih.gov/pubmed/28004395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22660
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller